pindolol has been researched along with Nephrosclerosis in 1 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
Nephrosclerosis: Hardening of the KIDNEY due to infiltration by fibrous connective tissue (FIBROSIS), usually caused by renovascular diseases or chronic HYPERTENSION. Nephrosclerosis leads to renal ISCHEMIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamashita, K | 1 |
| Shigematsu, K | 1 |
| Maeda, T | 1 |
| Ishida, Y | 1 |
| Niwa, M | 1 |
| Ozaki, M | 1 |
1 other study available for pindolol and Nephrosclerosis
| Article | Year |
|---|---|
[Antihypertensive effect of bopindolol on stroke-prone spontaneously hypertensive rats (SHRSP)].
Topics: Administration, Oral; Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; | 1989 |